International Stroke Conference 2025  /  Stroke Prevention in the United States and Europe (a European Stroke Organisation / ASA Joint Symposium)  /  The Next Generation of Clinical Trials in Stroke Prevention: Crossing Borders
Logo

American Heart Association

  10
  0

Final ID:

The Next Generation of Clinical Trials in Stroke Prevention: Crossing Borders

  • Kelly, Peter  ( MATER UNIVERSITY HOSPITAL , Dublin 7 , Ireland )
  • Kamel, Hooman  ( Weill Cornell Medicine , New York , New York , United States )
    • Author Disclosures:
    Peter Kelly: DO NOT have relevant financial relationships | Hooman Kamel: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Financial disclosures for Hooman Kamel: a PI role in the ARCADIA trial, which received in-kind study drug from the BMS-Pfizer Alliance for Eliquis and ancillary study support from Roche Diagnostics; a Deputy Editor role for JAMA Neurology; clinical trial steering/executive committee roles for the STROKE-AF (Medtronic), LIBREXIA-AF (Janssen), and LAAOS-4 (Boston Scientific) trials; consulting or endpoint adjudication committee roles for AbbVie, AstraZeneca, Boehringer Ingelheim, and Novo Nordisk; and household ownership interests in TETMedical, Spectrum Plastics Group, and Ascential Technologies.:Active (exists now)
Meeting Info:

International Stroke Conference 2025

2025

Los Angeles, CA

Session Info:

Stroke Prevention in the United States and Europe (a European Stroke Organisation / ASA Joint Symposium)

Wednesday, 02/05/2025 , 07:30AM - 09:00AM

ISC Invited Symposium

More abstracts on this topic:
The Future of Stroke in Europe

Veltkamp Roland, Wolfe Charles

AHA 2024 Guideline on Primary Prevention of Ischemic Stroke

Bushnell Cheryl, Sharrief Anjail

More abstracts from these authors:
The Trouble with ESUS: What do the studies tell us? Where do we do from here?

Kamel Hooman, Messe Steven

Atrial Cardiopathy and Cryptogenic Stroke

Kamel Hooman

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.

   Rate this abstract  (Maximum characters: 500)